Google
OACCW Stock Price & Analysis — Oaktree Acquisition Corp. III Life Sciences Warrant
OACCW FAQ
What is OACCW's ROE?
Oaktree Acquisition Corp. III Life Sciences Warrant reports a Return on Equity (ROE) of 3.58%.
What is OACCW's dividend yield?
Oaktree Acquisition Corp. III Life Sciences Warrant offers a dividend yield of 0.00%.
What is OACCW's Quality Score?
Our AI rates OACCW's overall financial quality at 69 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy OACCW?
Our AI Timing Score for OACCW is 5 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
OACCW AI Analysis Summary
Our AI summary for OACCW: Oaktree Acquisition Corp. III Life Sciences Warrant (NASDAQ). The stock currently trades at a P/E of 0.00, ROE of 3.58%, a dividend yield of 0.00%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 5/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 1.02
Price
0.08
(8.51%)
Day Change
|
|
|---|
OACCW, the overall quality is ok ( Quality = 69) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROE is relatively low.
Historical ROE is relatively low
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.02 |
| PBV / Sector |
N/A / N/A
|
| Earning Per Share | N/A |
| PE / Sector |
N/A / N/A
|
| PEG or PE/Growth / Sector |
N/A / N/A
|
| Average 1M Daily Value |
5330.951850000000
|
| Average 1W Daily Value |
1447.522000000000
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
8% |
| Registration Details |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 333 South Grand Avenue, Los Angeles, CA, United States, 90071
Phone: 213 830 6300
Website: https://www.oaktreeacquisitioncorp.com/oac-iii
Sector: -
Description: Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
